Unité d'Onco-Hémato-Immunologie pédiatrique, CHU Angers, 4 rue Larrey, 49933, Angers, France.
Service de Pédiatrie générale, CHU Angers, Angers, France.
Pediatr Rheumatol Online J. 2020 Jan 2;18(1):1. doi: 10.1186/s12969-019-0376-8.
The aim of this study was to identify early clinical and laboratory features that distinguish acute lymphoblastic leukemia (ALL) from juvenile idiopathic arthritis (JIA) in children presenting with persistent bone or joint pain for at least 1 month.
We performed a multicenter case-control study and reviewed medical records of children who initially presented with bone or joint pain lasting for at least 1 month, all of whom were given a secondary diagnosis of JIA or ALL, in four French University Hospitals. Each patient with ALL was paired by age with two children with JIA. Logistic regression was used to compare clinical and laboratory data from the two groups.
Forty-nine children with ALL and 98 with JIA were included. The single most important feature distinguishing ALL from JIA was the presence of hepatomegaly, splenomegaly or lymphadenopathy; at least one of these manifestations was present in 37 cases with ALL, but only in 2 controls with JIA, for an odds ratio (OR) of 154 [95%CI: 30-793] (regression coefficient: 5.0). If the presence of these findings is missed or disregarded, multivariate analyses showed that non-articular bone pain and/or general symptoms (asthenia, anorexia or weight loss) (regression coefficient: 4.8, OR 124 [95%CI: 11.4-236]), neutrophils < 2 × 10/L (regression coefficient: 3.9, OR 50 [95%CI: 4.3-58]), and platelets < 300 × 10/L (regression coefficient: 2.6, OR 14 [95%CI: 2.3-83.9]) were associated with the presence of ALL (area under the ROC curve: 0.96 [95%CI: 0.93-0.99]).
Based on our findings we propose the following preliminary decision tree to be tested in prospective studies: in children presenting with at least 1 month of osteoarticular pain and no obvious ALL in peripheral smear, perform a bone marrow examination if hepatomegaly, splenomegaly or lymphadenopathy is present. If these manifestations are absent, perform a bone marrow examination if there is fever or elevated inflammatory markers associated with non-articular bone pain, general symptoms (asthenia, anorexia or weight loss), neutrophils < 2 × 10/L or platelets < 300 × 10/L.
本研究旨在确定具有至少 1 个月持续性骨或关节疼痛的儿童中,急性淋巴细胞白血病(ALL)与幼年特发性关节炎(JIA)之间的早期临床和实验室特征。
我们进行了一项多中心病例对照研究,回顾了在法国四家大学医院就诊的 49 例 ALL 和 98 例 JIA 患儿的病历。每位 ALL 患儿均按年龄与 2 例 JIA 患儿配对。使用逻辑回归比较两组的临床和实验室数据。
共纳入 49 例 ALL 和 98 例 JIA 患儿。鉴别 ALL 和 JIA 的最重要的单一特征是存在肝脾肿大或淋巴结肿大;37 例 ALL 患儿中至少存在一种这些表现,而 2 例 JIA 对照中仅存在 1 例,比值比(OR)为 154 [95%CI:30-793](回归系数:5.0)。如果这些表现被遗漏或忽略,多变量分析显示非关节性骨痛和/或全身症状(乏力、厌食或体重减轻)(回归系数:4.8,OR 124 [95%CI:11.4-236])、中性粒细胞<2×10/L(回归系数:3.9,OR 50 [95%CI:4.3-58])和血小板<300×10/L(回归系数:2.6,OR 14 [95%CI:2.3-83.9])与 ALL 存在相关(ROC 曲线下面积:0.96 [95%CI:0.93-0.99])。
根据我们的研究结果,我们提出了以下初步决策树,供前瞻性研究测试:在具有至少 1 个月骨关节炎疼痛且外周血涂片无明显 ALL 表现的儿童中,如果存在肝脾肿大或淋巴结肿大,则进行骨髓检查。如果这些表现不存在,则如果存在发热或与非关节性骨痛、全身症状(乏力、厌食或体重减轻)、中性粒细胞<2×10/L 或血小板<300×10/L 相关的炎症标志物升高,则进行骨髓检查。